Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification in drug design, enhancing binding affinity to target proteins. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where the morpholine ring contributes to solubility and metabolic stability. Also utilized in agrochemical research for designing bioactive molecules with improved efficacy. The hydrochloride salt form enhances handling and reactivity in coupling reactions during multi-step organic synthesis.